HIV/AIDS Diagnostics
Rapid HIV tests more cost effective than ELISAs in low-risk populations
Published in TB and Outbreaks Week, December 6th, 2005
"Mother-to-child transmission of human immunodeficiency virus is the most common cause of pediatric human immunodeficiency virus in the United States; the Centers for Disease Control and Prevention recommendations endorse rapid human immunodeficiency virus testing for women with unknown viral status to quicken antiretroviral therapy.
"We compared the cost-effectiveness of Oraquick (Orasure Technologies, Bethlehem, Pa) rapid testing versus enzyme-linked immunosorbent assay testing for a low-risk population of Mexican American...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Auricular Chondritis
Ear piercing associated with auricular chondritis outbreak - Diagnostics
Clinical and radiologic findings in pulmonary paragonimiasis frequently mimic lung cancer or TB - Epidemiology
Syphilis is epidemic among homosexually active HIV-infected and uninfected men in Sydney - Gastroenteritis
Rising ocean temperatures contribute V. parahaemolyticus gastroenteritis outbreak - Preventive Medicine
Screening high TB-prevalent immigrants by chest X-ray allows for early detection and treatment - Adverse Drug Reaction
Adverse events similar between levofloxacin and conventional first-line regimens for active TB - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
